» Articles » PMID: 32007472

Prevalence, Risk Factors, and Erectile Dysfunction Associated With Peyronie's Disease Among Men Seeking Urological Care

Overview
Journal Sex Med
Date 2020 Feb 3
PMID 32007472
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Peyronie's disease (PD) is a connective tissue disorder of the penis characterized by an abnormality in collagen structure of penile tunica albuginea.

Aim: We sought to investigate the prevalence, risk factors, and the relationship between erectile dysfunction (ED) and PD in male patients aged 30-80 years seeking urological care.

Methods: This is a cross-sectional study using data collected from October 2016 to October 2017 in an outpatient clinic associated with the Brazilian Public Health System. All men aged 30 to 80 years were invited to participate. Data collected were related to the clinical history and sexual habits of patients using the International Index of Erectile Function, in addition to the physical examination of the penis and laboratory parameters.

Main Outcome Measure: Descriptive statistics and multivariate logistic regression models tested the prevalence, risk factors, and the relationship between ED and PD in male patients.

Results: The study included 656 individuals, who were distributed as per age, marital status, race, educational level, and income. Of these participants, 86 (13.11%) presented with fibrous plaques compatible with PD at the physical examination. Among the risk factors evaluated, PD was associated with diabetes, smoking, and obesity in 43.02, 64.17, and 26.74% of patients, respectively. The presence of penile plaques compatible with PD was more prevalent in men with ED, history of penile trauma, and complaint of penile deformity. There was a higher prevalence of plaques in the distal penis.

Conclusion: The PD among the studied population was associated with risk factors such as diabetes, smoking, and obesity. Other clinical characteristics, such as history of penile trauma, penile deformity, and ED, were reported in patients with PD. There was a higher prevalence of plaques in the distal penis, specifically in the corona of the glans penis. The prevalence of PD was different from that in the published literature, our results show that numbers thus more studies are needed. Segundo A, Glina S. Prevalence, Risk Factors, and Erectile Dysfunction Associated With Peyronie's Disease Among Men Seeking Urological Care. Sex Med 2020;8:230-236.

Citing Articles

Development of a new Peyronie's disease self-assessment screening app.

Broderick G, Mills J, Bathish L, Davis C, Khera M Transl Androl Urol. 2024; 13(11):2617-2624.

PMID: 39698562 PMC: 11650355. DOI: 10.21037/tau-24-273.


The multifaceted nature of diabetic erectile dysfunction: uncovering the intricate mechanisms and treatment strategies.

Ma J, Chen Y, Si Y, Qian J, Wang C, Jin J Front Endocrinol (Lausanne). 2024; 15:1460033.

PMID: 39583965 PMC: 11581859. DOI: 10.3389/fendo.2024.1460033.


Use of thermographic imaging for the evaluation of erectile dysfunction and Peyronie's disease.

Crisostomo-Wynne T, Hertz A, Maloney T, Walter J, Caras R Int J Impot Res. 2024; 36(7):755-758.

PMID: 39004622 DOI: 10.1038/s41443-024-00950-2.


Penile prosthesis implantation is safe and effective in Peyronie's disease patients with and without erectile dysfunction.

Moncada I, Krishnappa P, Zaccaro C, Fraile A, Romero-Otero J, Martinez-Salamanca J Int J Impot Res. 2024; 37(1):61-65.

PMID: 38909107 DOI: 10.1038/s41443-024-00938-y.


Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.

Phua T Front Aging. 2023; 4:1196648.

PMID: 37384143 PMC: 10293850. DOI: 10.3389/fragi.2023.1196648.


References
1.
Romero F, Romero A, Almeida R, Oliveira Jr F, Filho Jr R . Prevalence and risk factors for penile lesions/anomalies in a cohort of Brazilian men ≥ 40 years of age. Int Braz J Urol. 2013; 39(1):55-62. DOI: 10.1590/S1677-5538.IBJU.2013.01.08. View

2.
Abern M, Larsen S, Levine L . Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. J Sex Med. 2011; 9(1):288-95. DOI: 10.1111/j.1743-6109.2011.02519.x. View

3.
El-Sakka A, Tayeb K . Peyronie's disease in diabetic patients being screened for erectile dysfunction. J Urol. 2005; 174(3):1026-30. DOI: 10.1097/01.ju.0000170231.51306.32. View

4.
Usta M, Bivalacqua T, Jabren G, Myers L, Sanabria J, Sikka S . Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. J Urol. 2004; 171(2 Pt 1):775-9. DOI: 10.1097/01.ju.0000097498.34847.7c. View

5.
Lindsay M, Schain D, Grambsch P, Benson R, Beard C, Kurland L . The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991; 146(4):1007-9. DOI: 10.1016/s0022-5347(17)37988-0. View